Research

Life Sciences & Biotechnology

Title :

A randomized, double-blind, placebo and active controlled, multicenter, phase 3 study to access the efficacy and safety of Filgotinib administered for 52 weeks in combination with Methotrexate (MTX) to subjects with moderately to severely active rheumatoid arthritis, who have an inadequate response to methotrexate

Area of research :

Life Sciences & Biotechnology, Medical Sciences

Focus area :

Orthopedics

Principal Investigator :

Dr Uma Kumar, Professor & Head, All India Institute of Medical Sciences (AIIMS), New Delhi

Timeline Start Year :

2018

Timeline End Year :

2019

Contact info :

Details

Total Budget (INR):

 7,00,000

Organizations involved

Implementing Agency :

All India Institute of Medical Sciences (AIIMS), New Delhi

Funding Agency :

Gilead Sciences, Inc., USA

Related Research

A computational pipeline for understanding disease-causing mutations in Genomes Algorithms for context analysis and development of prediction tools Aim-1: A computational pipeline for identifying the context of key mutations in cancer genomes AIM-2: Development of computational tools for analysis and prediction of disease causing mutations
A proteomic investigation to outline the mechanism associated to non response to corticosteroids therapy in patients with severe alcoholic hepatitis
A randomized trial comparing oral misoprostol alone with oral misoprostol followed by oxytocin in women induced for hypertension of pregnancy
A study to assess and correlate serum levels of creatinine with muscle mass among patients with diabetes and pre- diabetes at a tertiary care hospital in Uttarakhand.
AINP on neonatal mortality in farm animals